{"id":"https://openalex.org/W1997444366","doi":"https://doi.org/10.1016/s0091-3057(02)00766-9","title":"Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine","display_name":"Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine","alternate_titles":[],"publication_year":2002,"publication_date":"2002-07-01","ids":{"openalex":"https://openalex.org/W1997444366","doi":"https://doi.org/10.1016/s0091-3057(02)00766-9","mag":"1997444366","pmid":"https://pubmed.ncbi.nlm.nih.gov/12062565"},"language":"en","primary_location":{"id":"doi:10.1016/s0091-3057(02)00766-9","doi":"https://doi.org/10.1016/s0091-3057(02)00766-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0091-3057(02)00766-9","pdf_url":null,"source":{"id":"https://openalex.org/S59685179","display_name":"Pharmacology Biochemistry and Behavior","issn_l":"0091-3057","issn":["0091-3057","1873-5177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Biochemistry and Behavior","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1997444366"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082184731","display_name":"Jordan Mechanic","orcid":"https://orcid.org/0000-0002-3303-5571","observed_orcids":["https://orcid.org/0000-0002-3303-5571"]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jordan A Mechanic","raw_affiliation_strings":["Psychobiology Laboratories, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Room 302-R, 800 Northeast 13th Street, Oklahoma City, OK 73190-3000, USA. jordan-mechanic@ouhsc.edu","Psychobiology Laboratories, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Room 302-R, 800 Northeast 13th Street, Oklahoma City, OK 73190-3000, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychobiology Laboratories, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Room 302-R, 800 Northeast 13th Street, Oklahoma City, OK 73190-3000, USA. jordan-mechanic@ouhsc.edu","institution_ids":["https://openalex.org/I49332381"]},{"raw_affiliation_string":"Psychobiology Laboratories, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Room 302-R, 800 Northeast 13th Street, Oklahoma City, OK 73190-3000, USA","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068240886","display_name":"Jill A. Wasielewski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jill A Wasielewski","raw_affiliation_strings":["Psychobiology Laboratories, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Room 302-R, 800 Northeast 13th Street, Oklahoma City, OK 73190-3000, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychobiology Laboratories, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Room 302-R, 800 Northeast 13th Street, Oklahoma City, OK 73190-3000, USA","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111564626","display_name":"Kathy L. Carl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kathy L Carl","raw_affiliation_strings":["Psychobiology Laboratories, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Room 302-R, 800 Northeast 13th Street, Oklahoma City, OK 73190-3000, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychobiology Laboratories, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Room 302-R, 800 Northeast 13th Street, Oklahoma City, OK 73190-3000, USA","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110318460","display_name":"Frank A. Holloway","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frank A Holloway","raw_affiliation_strings":["Psychobiology Laboratories, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Room 302-R, 800 Northeast 13th Street, Oklahoma City, OK 73190-3000, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychobiology Laboratories, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Room 302-R, 800 Northeast 13th Street, Oklahoma City, OK 73190-3000, USA","institution_ids":["https://openalex.org/I49332381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5082184731"],"corresponding_institution_ids":["https://openalex.org/I49332381"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":null,"fwci":0.387,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.46632859,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"72","issue":"4","first_page":"767","last_page":"777"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.017400000244379044,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/amphetamine","display_name":"amphetamine","score":0.9079999923706055},{"id":"https://openalex.org/keywords/drug-discrimination","display_name":"drug discrimination","score":0.9409999847412109},{"id":"https://openalex.org/keywords/discriminative-stimuli","display_name":"discriminative stimulus","score":0.5569999814033508},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9240000247955322},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5080000162124634},{"id":"https://openalex.org/keywords/subjective-drug-effects","display_name":"subjective drug effects","score":0.41100001335144043},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.9486459493637085},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.7883604764938354},{"id":"https://openalex.org/C97931131","wikidata":"https://www.wikidata.org/wiki/Q5282087","display_name":"Discriminative model","level":2,"score":0.6428418159484863},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6383010745048523},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5731931924819946},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.5187345147132874},{"id":"https://openalex.org/C3019878999","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic drug","level":4,"score":0.4850670397281647},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3983600437641144},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3608085811138153},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.28864526748657227},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.24934369325637817},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.22078952193260193},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.09515818953514099},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0892382562160492},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.062314897775650024}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003216","descriptor_name":"Conditioning, Operant","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003463","descriptor_name":"Cues","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004192","descriptor_name":"Discrimination, Psychological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012055","descriptor_name":"Reinforcement Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0091-3057(02)00766-9","doi":"https://doi.org/10.1016/s0091-3057(02)00766-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0091-3057(02)00766-9","pdf_url":null,"source":{"id":"https://openalex.org/S59685179","display_name":"Pharmacology Biochemistry and Behavior","issn_l":"0091-3057","issn":["0091-3057","1873-5177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Biochemistry and Behavior","raw_type":"journal-article"},{"id":"pmid:12062565","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12062565","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology, biochemistry, and behavior","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8999999761581421}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8673947225","display_name":null,"funder_award_id":"5 T32 DAO 7248","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":65,"referenced_works":["https://openalex.org/W59840460","https://openalex.org/W66092435","https://openalex.org/W82112911","https://openalex.org/W299136782","https://openalex.org/W399154554","https://openalex.org/W593527748","https://openalex.org/W989905880","https://openalex.org/W1508421599","https://openalex.org/W1847095494","https://openalex.org/W1902488471","https://openalex.org/W1903794187","https://openalex.org/W1966699659","https://openalex.org/W1969467943","https://openalex.org/W1973994989","https://openalex.org/W1975672751","https://openalex.org/W1976213197","https://openalex.org/W1979910512","https://openalex.org/W1982139530","https://openalex.org/W1982714327","https://openalex.org/W1983655448","https://openalex.org/W1991647317","https://openalex.org/W1993032100","https://openalex.org/W2002664886","https://openalex.org/W2006992287","https://openalex.org/W2016467106","https://openalex.org/W2019428032","https://openalex.org/W2033552965","https://openalex.org/W2038235621","https://openalex.org/W2040907210","https://openalex.org/W2042492822","https://openalex.org/W2045296126","https://openalex.org/W2046684510","https://openalex.org/W2050019172","https://openalex.org/W2054370088","https://openalex.org/W2055275469","https://openalex.org/W2056927210","https://openalex.org/W2058175453","https://openalex.org/W2059689375","https://openalex.org/W2061066502","https://openalex.org/W2061837419","https://openalex.org/W2072651043","https://openalex.org/W2072697155","https://openalex.org/W2075174032","https://openalex.org/W2077372686","https://openalex.org/W2080405819","https://openalex.org/W2082077747","https://openalex.org/W2083252023","https://openalex.org/W2084275938","https://openalex.org/W2089056997","https://openalex.org/W2089167026","https://openalex.org/W2092998813","https://openalex.org/W2139997418","https://openalex.org/W2146091186","https://openalex.org/W2147782024","https://openalex.org/W2151862550","https://openalex.org/W2322549652","https://openalex.org/W2402125115","https://openalex.org/W2414944070","https://openalex.org/W2478765828","https://openalex.org/W2506121317","https://openalex.org/W2729527893","https://openalex.org/W2731939072","https://openalex.org/W3144372880","https://openalex.org/W4229836878","https://openalex.org/W4302420761"],"related_works":["https://openalex.org/W2055275469","https://openalex.org/W2016023914","https://openalex.org/W2000156382","https://openalex.org/W2061837419","https://openalex.org/W2022513013","https://openalex.org/W2020098992","https://openalex.org/W2000722108","https://openalex.org/W1991178125","https://openalex.org/W2402791288","https://openalex.org/W2101771761"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1997444366","counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
